Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections.
Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections. J Thorac Cardiovasc Surg. 2019 12; 158(6):1614-1623.
View in:
PubMed
subject areas
Cord Blood Stem Cell Transplantation
Cord Blood Stem Cell Transplantation
Feasibility Studies
Feasibility Studies
Female
Female
Humans
Humans
Hypoplastic Left Heart Syndrome
Hypoplastic Left Heart Syndrome
Infant
Infant
Male
Male
Palliative Care
Palliative Care
Prospective Studies
Prospective Studies
Recovery of Function
Recovery of Function
Regeneration
Regeneration
Time Factors
Time Factors
Transplantation, Autologous
Transplantation, Autologous
Treatment Outcome
Treatment Outcome
United States
United States
Ventricular Function, Right
Ventricular Function, Right
authors with profiles
Harold M Burkhart